Non-Antibody Products — page 2 of 48,825
Non-Antibody Products
Page 2 of 48,825
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| A77 1726 | Purity ≥98% by HPLC. Background: Physiologically active metabolite of t… | 5 mg, 25 mg | MBS842963 |
 MYBIOSOURCE INC. |
More Info |
| A77-01 | Purity ≥98%. MW: 286.33 | 2 mg, 5 mg, 1ml/10mM (in DMSO) | MBS577536 |
MYBIOSOURCE INC. |
More Info |
| A77-01 | Purity ≥98%. MW: 286.338 | 100 mg, 500 mg | MBS130865 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98% (TLC). MW: 357.8 | 10 mg, 50 mg | MBS565381 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98% by TLC. Background: A-803467 is a potent, selective inhibit… | 5 mg, 25 mg | MBS842200 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98%. MW: 357.79 | 100 mg, 500 mg | MBS132100 |
MYBIOSOURCE INC. |
More Info |
| A-803467 | Purity ≥98%. MW: 357.79 | 1ml/10mM (in DMSO), 10 mg, 25 mg | MBS575739 |
MYBIOSOURCE INC. |
More Info |
| A-804598 | Purity >98%. A-804598 is a P2X7 selective, competitive antagonist with the… | 5 mg, 10 mg, 25 mg | MBS384094 |
MYBIOSOURCE INC. |
More Info |
| A83-01 | Purity >98% (TLC); NMR (Conforms). ALK inhibitor. Selective glycogen synth… | 5 mg, 25 mg | MBS515040 |
MYBIOSOURCE INC. |
More Info |
| A-83-01 | Purity 97%+. MW: 421.52 | 2 mg, 5 mg, 10 mg | MBS575483 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | A-966492 is a highly potent and efficacious poly(ADP-ribose) polymerase (P… | 10 mg | MBS8506196 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity ≥98%. A-966492 is a novel and potent inhibitor of PARP1 and PARP… | 2 mg, 5 mg, 1ml/10mM (in DMSO) | MBS578914 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity ≥98%. MW: 324.359 | 100 mg, 500 mg | MBS132689 |
MYBIOSOURCE INC. |
More Info |
| A-966492 | Purity >98%. A-966492 displayed high potency against the poly(ADP-ribose)… | 5 mg, 1 mL (in DMSO), 10 mg | MBS384096 |
MYBIOSOURCE INC. |
More Info |
| 293A | The HEK 293A cell line is an immortalized line of primary human embryonic… | 1 vial | ABI-TC1333 |
 ACCEGEN BIOTECH |
More Info |
| A10.7 | Species: human. Derived from metastatic liver tumor (clinical stage IV). | 1 vial | ABC-TC533S |
ACCEGEN BIOTECH |
More Info |
| A-172 | Species: human. Organ: brain Disease: glioblastoma. | 1 vial | ABC-TC0022 |
ACCEGEN BIOTECH |
More Info |
| A-204 | Human Muscle Rhabdomyosarcoma cell line. The A-204 cell line was establish… | 1 vial | ABC-TC445S |
ACCEGEN BIOTECH |
More Info |
| A2058 | Species: human. Malignant melanoma, metastasis to lymph node. | 1 vial | ABC-TC0023 |
ACCEGEN BIOTECH |
More Info |
| A-253 | The A253 line is one of thirteen to be isolated and partially characterize… | 1 vial | ABC-TC0024 |
ACCEGEN BIOTECH |
More Info |
| A375 | Species: human. This line was derived from a 54 year old female with malig… | 1 vial | ABC-TC0026 |
ACCEGEN BIOTECH |
More Info |
| A-427 | Species: human. A-427 cell line was established from the lung carcinoma of… | 1 vial | ABC-TC1339 |
ACCEGEN BIOTECH |
More Info |
| A-431 | Species: human. The epidermoid carcinoma cell line A-431, derived from an… | 1 vial | ABC-TC0030 |
ACCEGEN BIOTECH |
More Info |
| A-498 | Species: human. Established from the kidney carcinoma of a 52-year-old man… | 1 vial | ABC-TC0031 |
ACCEGEN BIOTECH |
More Info |
| A549 | Species: human. A549 cell line was initiated in 1972 by D.J. Giard, et al.… | 1 vial | ABC-TC0032 |
ACCEGEN BIOTECH |
More Info |
| A6 | Frog (Xenopus laevis) cell line derived from kidney. Lifespan: infinite. | 1 vial | ABC-TC020S |
ACCEGEN BIOTECH |
More Info |
| A-673 | Species: human. Tissue: muscle Disease: rhabdomyosarcoma. | 1 vial | ABC-TC0034 |
ACCEGEN BIOTECH |
More Info |
| A-704 | Human kidney adenocarcinoma. Derived from 78-year-old male. Does not produ… | 1 vial | ABC-TC0021 |
ACCEGEN BIOTECH |
More Info |
| A-72 | Canine Golden Retriever tumour. Derived from tumour of thigh (unknown hist… | 1 vial | ABC-TC0036 |
ACCEGEN BIOTECH |
More Info |
| A9 | Mouse C3H / An areolar and adipose tissue. Derivative of L929 selected in… | 1 vial | ABC-TC0037 |
ACCEGEN BIOTECH |
More Info |
| 1A-116 | 1A-116 is a specific Rac1 inhibitor. Purity >98%. MW: 307.32. | 100 mg | orb525723 |
 BIORBYT LTD. |
More Info |
| A 438079 | Purity >98%. MW: 306.15. | 100 mg | orb654683 |
BIORBYT LTD. |
More Info |
| A 804598 | Purity >98%. MW: 315.37. | 100 mg | orb16594 |
BIORBYT LTD. |
More Info |
| A 83-01 | Purity >98%. MW: 421.52. | 5 mg | orb610367 |
BIORBYT LTD. |
More Info |
| A 922500 | Purity >98%. MW: 428.48. | 100 mg | orb180904 |
BIORBYT LTD. |
More Info |
| A1120 | MW: 392.3782. | 100 mg | orb692106 |
BIORBYT LTD. |
More Info |
| A1155463 | Purity >98%. | 100 mg | orb385568 |
BIORBYT LTD. |
More Info |
| A-1210477 | Purity >98%. MW: 850.04. | 100 mg | orb320160 |
BIORBYT LTD. |
More Info |
| A-1331852 | n/a | 100 mg | orb363688 |
BIORBYT LTD. |
More Info |
| A1874 | Purity >98%. MW: 1173.597. | 100 mg | orb611292 |
BIORBYT LTD. |
More Info |
| A-196 | Purity >98%. MW: 359.2. | 5 mg | orb636770 |
BIORBYT LTD. |
More Info |
| A-196 | Purity >98%. MW: 359.25. | 100 mg | orb413193 |
BIORBYT LTD. |
More Info |
| A-205804 | Purity >98%. MW: 300.4. | 100 mg | orb180910 |
BIORBYT LTD. |
More Info |
| A-23187 | Purity >98%. MW: 523.62. | 5 mg | orb340508 |
BIORBYT LTD. |
More Info |
| A2793 | MW: 265.69. | 100 mg | orb783559 |
BIORBYT LTD. |
More Info |
| A286982 | A286982 is an inhibitor that blocks the integrin-ligand interaction betwee… | 100 mg | orb746361 |
BIORBYT LTD. |
More Info |
| A-366 | Purity >98%. MW: 329.44. | 100 mg | orb341513 |
BIORBYT LTD. |
More Info |
| A-381393 | Purity >98%. MW: 320.44. | 100 mg | orb573240 |
BIORBYT LTD. |
More Info |
| A-420983 | Purity >98%. MW: 593.73. | 100 mg | orb573446 |
BIORBYT LTD. |
More Info |
| A-484954 | Purity >98%. MW: 289.29. | 100 mg | orb572970 |
BIORBYT LTD. |
More Info |